Stock Market News

Epic Research Update : Suven Life Sciences

Suven Life Sciences
Epic Update Suven Life Sciences

Suven Life Sciences (Suven) has received three product patents one each from Canada, China and India corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2025.

For more information  – 0731-6642300 or Visit https://www.epicresearch.co/

Share Button
Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300
https://www.epicresearch.co/